Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

ZBTB33, Rabbit, Monoclonal Antibody, Abnova™

Rabbit monoclonal antibody raised against a human ZBTB33 peptide using ARM Technology.

Supplier:  Abnova Corporation H00010009K

Catalog No. 89-201-494


Includes: Up to three rabbit IgG clones of 1mg each will be delivered to customer.

Description

Description

KAISO is a transcriptional regulator that binds, via its zinc fingers, to DNA sequences containing methylated CGCG or to the consensus KAISO-binding site (KBS) TCCTGCNA (Filion et al., 2006 [PubMed 16354688]).[supplied by OMIM

Library Construction: Nonfusion antibody library from rabbit spleen (ARM Technology)
Expression: Overexpression vector and transfection into 293H cell line

Order Info

  1. Customer may provide cell or tissue lysate for antibody screening.
  2. Rabbit monoclonal antibody generated by ARM technology is amenable to antibody engineering including F(ab)2, IgG, scFv and different Fc and non-Fc conjugates per customer request.

Specifications

Specifications

ZBTB33
Monoclonal
Unconjugated
In 1X PBS, pH 7.4
ZBTB33
ZBTB33
A synthetic peptide of human ZBTB33
RUO
10009
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
IgG
ELISA, Western Blot
1mg
zinc finger and BTB domain containing 33
ZBTB33
ZNF-kaiso, ZNF348
Rabbit
1 mg x up to 3 Abs
Primary
Human
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.